Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Kentaro Tanaka

Assistant Professor

Kyushu University

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

60%

Internal Medicine

20%

Oncology

50%

Targeted Therapy

40%

Lung Cancer

30%

Cancer Research

30%

Neoadjuvant Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non–Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)

Article Link

Year:

2022

A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index

Article Link

Year:

2022

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

Article Link

Year:

2022

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy

Article Link

Year:

2022

Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’: [ESMO Open Volume 6, Issue 4, August 2021, 100191] (ESMO Open (2021) 6(4), (S2059702921001526), (10.1016/j.esmoop.2021.100191))

Article Link

Year:

2022

Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma

Article Link

Year:

2022

Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer

Article Link

Year:

2022

A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)

Article Link

Year:

2021

A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)

Article Link

Year:

2021

A case of primary hepatic leiomyosarcoma treated with multi-line chemotherapy

Article Link

Year:

2021

Collaborators5

Tateaki Naito

Clinical Professor

St. Luke's International University

JAPAN

Hiroyuki Inoue

Associate Professor

Fukuoka University

JAPAN

Yuki Ikematsu

JAPAN

Shogo Nomura

Project Lecturer

University of Tokyo

JAPAN

Katsuyuki Kiura

Okayama University Hospital

JAPAN

How do I reach out?

Meet Kite AI